Jared Gollob

Insider Reports History

Location
Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jared Gollob:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Medical Officer Common Stock 109,992 $10,140,162 $92.19 08 Dec 2025 Direct
Kymera Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 34,083 08 Dec 2025 Direct

Insider Reports Filed by Jared Gollob

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 08 Dec 2025 8 -$4,109,026 4 Chief Medical Officer 08 Dec 2025, 18:09
KYMR Kymera Therapeutics, Inc. 15 Oct 2025 8 -$3,575,068 4 Chief Medical Officer 15 Oct 2025, 17:28
KYMR Kymera Therapeutics, Inc. 13 Oct 2025 5 -$184,392 4 Chief Medical Officer 14 Oct 2025, 17:11
KYMR Kymera Therapeutics, Inc. 03 Mar 2025 4 -$174,786 4 Chief Medical Officer 03 Mar 2025, 18:30
KYMR Kymera Therapeutics, Inc. 15 Jul 2024 7 -$1,720,775 4 Chief Medical Officer 16 Jul 2024, 18:00
KYMR Kymera Therapeutics, Inc. 01 Mar 2024 5 -$139,967 4 Chief Medical Officer 04 Mar 2024, 18:21
KYMR Kymera Therapeutics, Inc. 27 Feb 2024 3 -$17,168 4 Chief Medical Officer 29 Feb 2024, 16:34
KYMR Kymera Therapeutics, Inc. 09 Feb 2024 4 -$1,542,107 4 Chief Medical Officer 09 Feb 2024, 19:47
KYMR Kymera Therapeutics, Inc. 01 Mar 2023 4 -$40,233 4 Chief Medical Officer 03 Mar 2023, 15:30
KYMR Kymera Therapeutics, Inc. 04 May 2022 4 +$33,740 4 Chief Medical Officer 04 May 2022, 09:02
KYMR Kymera Therapeutics, Inc. 01 Mar 2022 2 $0 4 Chief Medical Officer 03 Mar 2022, 15:30
KYMR Kymera Therapeutics, Inc. 01 Nov 2021 13 -$3,506,684 4 Chief Medical Officer 02 Nov 2021, 18:45